News

Yasoo Health Ltd. receives a research grant from the European organization EUREKA for its Inflammatory Bowel Disease Program

February 1, 2007 - Yasoo Health Ltd (Yasoo) announced today that it has secured a research grant from the European organization EUREKA (www.eureka.be) to support its research and development work on a product for the management and adjuvant therapy of Inflammatory Bowel Disease (IBD).

The grant, worth in excess of $220.000 over the next two years, will enhance the ongoing collaboration between Yasoo, the Universities of Cyprus and Crete, and the biotechnology start up, Bionature E.A. Ltd. (www.bionature.com.cy) IBD is a chronic inflammatory condition affecting millions of people worldwide, often exacerbated by malabsorption of important nutrients and antioxidants. The anti-inflammatory effectiveness of antioxidant / anti-inflammatory compounds will be evaluated in cell and animal models of inflammation, while clinical studies are also being planned.

"This award validates our research work in the area of inflammation and it is further support of our strategy for developing safe and effective products through top quality, peer-reviewed laboratory and clinical research" said Dr Constantinos Neophytou, Director of International Operations and coordinator of the project.